Oxidative stress, anti‐oxidant therapies and chronic kidney disease

Abstract

Oxidative stress is an important mechanism of injury in chronic kidney disease. Potential pathways of oxidative stress mediating kidney injury are discussed. ABSTRACT:n ep_1572 311..321Chronic kidney disease (CKD) is a common and serious problem that adversely affects human health, limits longevity and increases costs to health-care systems worldwide. Its increasing incidence cannot be fully explained by traditional risk factors. Oxidative stress is prevalent in CKD patients and is considered to be an important pathogenic mechanism. Oxidative stress develops from an imbalance between free radical production often increased through dysfunctional mitochondria formed with increasing age, type 2 diabetes mellitus, inflammation, and reduced anti-oxidant defences. Perturbations in cellular oxidant handling influence downstream cellular signalling and, in the kidney, promote renal cell apoptosis and senescence, decreased regenerative ability of cells, and fibrosis. These factors have a stochastic deleterious effect on kidney function. The majority of studies investigating anti-oxidant treatments in CKD patients show a reduction in oxidative stress and many show improved renal function. Despite heterogeneity in the oxidative stress levels in the CKD population, there has been little effort to measure patient oxidative stress levels before the use of any anti-oxidants therapies to optimize outcome. This review describes the development of oxidative stress, how it can be measured, the involvement of mitochondrial dysfunction and the molecular pathways that are altered, the role of oxidative stress in CKD pathogenesis and an update on the amelioration of CKD using anti-oxidant therapies.

N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys

“…ROS act as mediators of Ang II-induced epithelial-mesenchymal transition (EMT) and apoptosis. The use of antioxidant therapy for the treatment of renal fibrosis has attracted wide interest in recent years [22] . Some reports have shown an interaction between ROS and RAS, but the relationship is still unclear.…”

Kidney Cadmium Toxicity, Diabetes and High Blood Pressure: The Perfect Storm

“…Green tea consumption appeared to increase HO-1 protein levels in lymphocytes in both L/L and S/S groups although the S/S group showed higher baseline levels of HO-1protein than the L/L group. This trial shows a promise of using regular green tea consumption to enhance HO-1 expression to reduce DNA damage that could delay the onset of chronic disease of high prevalence such as diabetes and CKD, known to be associated with increased oxidative stress and inflammation (Small et al 2012). However, further research is warranted to establish safe and effective bilirubin dose levels because of neurotoxicity potential of high serum bilirubin levels.…”

Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats

“…This imbalance is a situation that is referred to as oxidative stress. 201 Renal cells, particularly tubular cells, have a high metabolic activity and therefore have a high production rate of ROS. The major site of production of ROS is the mitochondria although endoplasmic reticulum, peroxisome and lysosomes may also contribute.…”